RussiaТs Nanolek says revenue triples to 2.6 bln rbl in 2017 - News Archive - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

RussiaТs Nanolek says revenue triples to 2.6 bln rbl in 2017

MOSCOW, Feb 13 (PRIME) -- The revenue of Russian biopharmaceutical company Nanolek, a subsidiary of state nanotechnology company Rusnano, tripled on the year to 2.6 billion rubles in 2017, the company said in a statement on Tuesday without providing accounting standards.

The companyТs production at the plant in the Kirov Region rose 20% to 8.1 million packs last year.

УThe companyТs plans for 2018 include strengthening of positions in directions that we chose Ц vaccines, medicines for treatment of orphan diseases, and retrovirus therapy. The company continues investment in portfolio development, in clinical tests, and in registration of new medicines. The combined investment portfolio will exceed 350 million rubles in 2018,Ф the company said quoting its President Vladimir Khristenko.

(58.0171 rubles Ц U.S. $1)

End

13.02.2018 18:05
 
 
Share |
To report an error select text and press Ctrl+Enter
 
 
Central Bank Official Rate
1W 1M 1Y
USD
EUR 75.2492 +0.2021 16 feb
USD 66.7044 +0.1615 16 feb
Stock Market Indices
1D 1W 1M 1Y
MICEX
rtsi 1177.50 +1.83 18:50 15 feb
micex 2490.16 +1.19 18:50 15 feb
Stock Quotes in RUR
1D 1W 1M 1Y
GAZP
gazp 159.04 +2.51 18:49 15 feb
lkoh 5426.00 +1.22 18:49 15 feb
rosn 403.50 +2.19 18:49 15 feb
sber 208.00 +1.75 18:49 15 feb
MICEX Ruble Trading
1D 1W 1M 1Y
USDTD
EURTD 75.1800 -0.2300 14:59 15 feb
USDTD 66.5875 -0.3200 17:44 15 feb